Načítá se...
“No evident disease activity”: The use of combined assessments in the management of patients with multiple sclerosis
Using combined endpoints to define no evident disease activity (NEDA) is becoming increasingly common when setting targets for treatment outcomes in multiple sclerosis (MS). Historically, NEDA has taken account of the occurrence of relapses, brain magnetic resonance imaging (MRI) lesions and disabil...
Uloženo v:
| Vydáno v: | Mult Scler |
|---|---|
| Hlavní autoři: | , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
SAGE Publications
2017
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5536258/ https://ncbi.nlm.nih.gov/pubmed/28381105 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1352458517703193 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|